Literature DB >> 10809113

Current therapy of cutaneous melanoma.

J D Wagner1, M S Gordon, T Y Chuang, J J Coleman.   

Abstract

Melanoma is a growing public health problem. Optimal care of the melanoma patient is multidisciplinary, but plastic surgeons and other surgical specialties play a central role in the management of these patients. Although surgery remains the mainstay of therapy for melanoma, several recent clinical studies have helped to clarify the biology of the disease and have changed the patterns of care for patients with melanoma. The advent of lymphatic mapping for interrogation of regional lymph nodes and interferon as the first effective postsurgical adjuvant therapy have had a major impact on the care of melanoma in the United States and elsewhere. This article will review the current clinical approach and therapy for cutaneous melanoma. The diagnosis, prognostic variables, staging evaluation, current surgical and medical treatment, and follow-up guidelines for patients with all stages of melanoma are reviewed. Recent studies, controversies, and directions of future investigational therapies will be discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10809113     DOI: 10.1097/00006534-200004050-00028

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  16 in total

Review 1.  Clinical and biological aspects of sentinel node biopsy in malignant melanoma--an update.

Authors:  Isabel Callejo Peixoto; José Meneses e Sousa
Journal:  Clin Transl Oncol       Date:  2005-05       Impact factor: 3.405

Review 2.  Resistance to chemotherapy and molecularly targeted therapies: rationale for combination therapy in malignant melanoma.

Authors:  S Wu; R K Singh
Journal:  Curr Mol Med       Date:  2011-10       Impact factor: 2.222

Review 3.  Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and management.

Authors:  Dongying Wang; Tianmin Xu; He Zhu; Junxue Dong; Li Fu
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 4.  Engineering nanomedicines for improved melanoma therapy: progress and promises.

Authors:  Di Bei; Jianing Meng; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

Review 5.  Targeting the RAS pathway in melanoma.

Authors:  Zhenyu Ji; Keith T Flaherty; Hensin Tsao
Journal:  Trends Mol Med       Date:  2011-09-30       Impact factor: 11.951

Review 6.  Treatment strategy for cutaneous malignant melanoma.

Authors:  Arata Tsutsumida; Hiroshi Furukawa; Yuhei Yamamoto; Tsuneki Sugihara
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

7.  [Operative therapy of acral melanomas].

Authors:  M Möhrle; V Lichte; H Breuninger
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

8.  Utility of frozen-section analysis of sentinel lymph node biopsy specimens for melanoma in surgical decision making.

Authors:  Weesam Alkhatib; Casey Hertzenberg; William Jewell; Mazin F Al-Kasspooles; Ivan Damjanov; Mark S Cohen
Journal:  Am J Surg       Date:  2008-12       Impact factor: 2.565

9.  Primary mucosal sinonasal melanoma-Case report and review of the literature. The role of complex treatment-surgery and adjuvant radiotherapy.

Authors:  Lena Marinova; Kaloyan Yordanov; Nikolay Sapundgiev
Journal:  Rep Pract Oncol Radiother       Date:  2010-12-21

10.  Molecular markers of tumor progression in melanoma.

Authors:  Joshua Rother; Dan Jones
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.